Omnibus bill clears Senate
This article was originally published in The Tan Sheet
Executive Summary
Amendment that would allocate $10 mil. in FDA funding "for the continuance of methamphetamine reduction efforts" passes Senate by voice vote Jan. 23. Proposed by Sen. Charles Grassley (R-Iowa), amendment is one of more than 200 considered by upper chamber before it passed omnibus spending package (H J Res 2) the same day in a 69-29 vote. Measure would provide FDA with $1.63 bil. in FY 2003, of which $412.4 mil. would be allocated to CFSAN, $426.2 mil. to CDER. NCCAM would receive $114.1 mil., roughly $9 mil. above House-approved level. Next step is conference with lower chamber, which passed its omnibus package Jan. 8; Hill sources say conference process could be resolved by the Presidents' Day recess, although Congress faces "tremendous hurdles"...
You may also be interested in...
Omnibus spending bill
House, Senate agree to conference report on FY 2003 approps bill Feb. 13, providing $413.3 mil. for CFSAN, $426.7 mil. for CDER. Total FDA budget is $1.63 bil., including $222.9 mil. in PDUFA fees. Funding levels are similar to those in version passed by lower chamber (1"The Tan Sheet," Jan. 27, 2003, In Brief)...
Approps continuing resolution
House passes H.J. Res 13 on Jan. 28, Senate the day after, extending continuing appropriations for FY 2003 through Feb. 7 while government awaits resolution of omnibus approps bill (1"The Tan Sheet" Jan. 27, 2003, p. 2)...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.